Effect of retinoids on LPS-induced COX-2 expression and COX-2 associated PGE2 release from mouse peritoneal macrophages and TNF-α release from rat peripheral blood mononuclear cells

Toxicology Letters

Volumn 150, Issue 2, 2004, Pages 191-201

  Kim, Bae Hwan ^a,b   Kang, Kyung Sun ^a   Lee, Yong Soon ^a  

^a Seoul National University   (South Korea)

^b AmorePacific Corporation   (South Korea)

Author keywords

Anti inflammation; COX 2; PGE2; Retinoids; TNF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; INDOMETACIN; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; RETINOIC ACID; RETINOL; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME INDUCTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED ICR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RETINOIDS; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN A;

EID: 1842861720     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2004.01.010     Document Type: Article

References (39)

1. Boehm B.A., Heyman R.A., Patel S., Stein R.B., Nagpal S. Retinoids: biological function and use in the treatment of dermatological diseases. Exp. Opin. Invest. Drugs. 4:1995;593-612.
2. Botting R. Regular article: COX-1 and COX-3 inhibitors. Thromb. Res. 110:2003;269-272.
3. 4-like activity in vitro. Eur. J. Pharmacol. 98:1984;61-67.
4. Chen Y.C., Shen S.C., Lee W.R., Hou W.C., Yang L.L., Lee T.J.F. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell. Biochem. 82:2001;537-548.
5. Datta P.K., Lianos E.A. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells. Kidney Int. 56:1999;486-493.
6. Devaux Y., Grosjean S., Seguin C., David V., Dousset B., Zannad F., Meistelman C., De Talance N., Mertes P.M., Ungureanu-Longrosis D. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. Am. J. Physiol. Endocrinol. Metab. 279:2000;1045-1053.
7. Driessen C., Hirv K., Rink L., Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res. 13:1994;15-20.
8. 2 by retinoids and flavonoids. Mechanism of action. Agents Actions. 25:1988;364-400.
9. Gabriel P., Cakman I., Rink L. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp. Geront. 37:2002;235-247.
10. 2 and TNF-α by nitric oxide in resting and LPS-activated RAW 264.7 cells. Cytokine. 19(4):2002;175-180.
11. Haraoui B., Wilder R.L., Allen J.B., Sporn M.B., Helfgott R.K., Brinckerhoff C.E. Dose-dependent suppression by the synthetic retinoid 4-hydroxyphenyl retinamide of streptococcal cell wall-induced arthritis in rats. Int. J. Immunopharmacol. 7:1985;903-916.
12. Juan J.M. Effect of retinoids on dermal inflammation and on arachidonic acid mobilization and metabolism in murine 3T6 fibroblasts retinoids, arachidonate release and metabolism. Int. J. Immunopharmacol. 18:1996;459-465.
13. Kanekura T., Higashi Y., Kanzaki T. Inhibitory effects of 9-cis-retinoic acid and pyrrolidinedithiocarbamate on cyclooxygenase (COX)-2 expression and cell growth in human skin squamous carcinoma cells. Cancer Lett. 161(2):2000;177-183.
14. Khuri F.R., Wu H., Lee J.J., Kemp B.L., Lotan R., Lippman S.M., Feng L., Hong W.K., Xu X.C. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin. Cancer Res. 7(4):2001;861-867.
15. Klein T., Nusing R.M., Pfeilsschifter J., Ulrich V. Selective inhibition of cyclooxygenase 2. Biochem. Pharmacol. 48:1994;1605-1610.
16. Kligman L.H., Sapadin A.N., Schwartz E. Peeling agents and irritants, unlike tretinoin, do not stimulate collagen synthesis in the photoaged hairless mouse. Arch. Dermatol. Res. 288:1996;615-620.
17. Lahti A., Kankaanranta H., Moilanen E. P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production. Eur. J. Pharmacol. 454:2002;115-123.
18. Lee S.H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267(36):1992;25934-25938.
19. Li G., Bush J.A., Ho V. Effect of retinoic acid on apoptosis and DNA repair in human keratinocytes after UVB irradiation. J. Cutan. Med. Surg. 4(1):2000;2-7.
20. Martin J.H., Alalami O., Yaqoob F. Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells. Oncol. Rep. 7:2000;219-223.
21. Mestre J.R., Subbaramaiah K., Sacks P.G., Schantz S.P., Tanabe T., Inoue H., Dannenberg A.J. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells. Cancer Res. 57(14):1997;2890-2895.
22. Mitchell J.M., Akarasereenont P., Thiemebermann C., Flower R.J., Vane J.R. Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A. 90:1994;11693-11697.
23. Morita I., Schindler M., Regier M.K., Otto J.C., Hori T., KeWitt D.L., Smith W.L. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and 2. J. Biol. Chem. 270:1995;10902-10908.
24. Moyad M.A. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: parts I & II. Semin. Urol. Oncol. 19(4):2001;294-316.
25. Muller G.M., Chen R., Huang S.Y., Corral L.G., Wong L.M., Patterson R.T., Chen Y., Kaplan G., Stirling D.L. Amino-substituted thalidomide analogs: potent inhibitors of TNF-α production. Bioorg. Med. Chem. Lett. 9:1999;1625-1630.
26. Newton R.C., Decicco C.P. Therapeutic potential and strategies for inhibiting tumor necrosis factor-α J. Med. Chem. 42(13):1999;2295-2314.
27. Oh G.S., Pae H.O., Seo W.G., Shin M.K., Kim I.K., Chai K.Y., Yun Y.G., Kwon T.O., Lim J.S., Chung H.T. Inhibitory effect of retinoic acid on expression of inducible nitric oxide synthase gene in L929 cells. Immunopharmacol. Immunotoxicol. 23:2001;335-342.
28. Orfanos C.E., Zoublis C.C., Almond-Roesler B., Geilen C.C. Current use and future potential role of retinoids in dermatology. Drugs. 53:1997;358-388.
29. Otto J.C., Smith W.L. Prostaglandin endoperoxide synthases-1 and 2. J. Lipid Mediat. Cell Signal. 12:1995;139-156.
30. Personett D., Fass U., Panickar K., McKinney M. Retinoic acid-mediated enhancement of the cholinergic/neuronal nitric oxide synthase phenotype of the medial septal SN56 clone; establishment of a nitric oxide-sensitive proapoptotic state. J. Neurochem. 74:2000;2412-2424.
31. Schwarz E.J., Reginato M.J., Shao D., Krakow S.L., Lazar M.A. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol. Cell Biol. 17(3):1997;1552-1561.
32. Sirsjo A., Gidlof A.C., Olsson A., Torma H., Ares M., Kleinert H., Forstermann U., Hansson G.K. Retinoic acid inhibits nitric oxide synthase-2 expression through the retinoic acid receptor-alpha. Biochem. Biophys. Res. Commun. 270:2000;846-851.
33. Smith W.L., DeWitt D.L. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to non-steroidal anti-inflammatory drugs. Semin. Nephrol. 15:1995;179-194.
34. Subbaramaiah K., Cole P.A., Dannenberg A.J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and independent mechanisms. Cancer Res. 62:2002;2522-2530.
35. Touhey S., O'Connor R., Plunkett S., Maguire A., Clynes M. Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. Identification of novel chemotherapeutic drug resistance modulators. Eur. J. Cancer. 38(12):2002;1661-1670.
36. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38:1998;97-120.
37. Vane J.R., Botting R.M. Anti-inflammatory drugs and their mechanism of action. Inflamm. Res. 47(Suppl. 2):1998;S78-S87.
38. Varani J., Fisher G.J., Kang S., Voorhees J.J. Molecular mechanisms of intrinsic skin aging and retinoid-induced repair and reversal. J. Invest. Dermatol. Symp. 3(1):1998;57-60.
39. Ye Y., Jackson K., Houslay M.D., Chandler L.J., O'Donnell J.M. Development of rolipram-sensitive, cyclic AMP phosphodiesterase (PDE4) in rat primary neuronal cultures. Dev. Brain Res. 130:2001;115-121.